Evolution from WHO to EASL and mRECIST for hepatocellular carcinoma: considerations for tumor response assessment.
about
Timing and extent of response in colorectal cancer: critical review of current data and implication for future trialsAngiogenesis Inhibitors for the Treatment of Hepatocellular CarcinomaDegradable Starch Microspheres Transcatheter Arterial Chemoembolization (DSM-TACE) in Intrahepatic Cholangiocellular Carcinoma (ICC): Results from a National Multi-Center Study on Safety and EfficacyCyberKnife Radiosurgery - Value as an Adjunct to Surgical Treatment of HCC?Follow-up of multicentric HCC according to the mRECIST criteria: role of 320-Row CT with semi-automatic 3D analysis software for evaluating the response to systemic therapyEvaluating tumor response with FDG PET: updates on PERCIST, comparison with EORTC criteria and clues to future developments.Principles of Kinase Inhibitor Therapy for Solid Tumors.Computed tomography imaging assessment of postexternal beam radiation changes of the liver.Transarterial chemoembolization (TACE) with degradable starch microspheres (DSM) in hepatocellular carcinoma (HCC): multi-center results on safety and efficacy.Safety and efficacy of transarterial chemoembolization with degradable starch microspheres (DSM-TACE) in the treatment of secondary liver malignancies.The physics of radioembolization
P2860
Q26797292-5FCF55AC-55AB-4C6E-95A7-BEA2CB7978E2Q28075305-7AC14E85-90AA-4C66-B118-8111D9EE20D0Q33439286-62139D9F-72A6-4111-95C5-BF8B52D512DEQ36957558-DDEDE953-67AA-45F7-B3D7-5A4AB6082BA8Q37600562-4D0C160C-E3F0-4C77-9560-D988F71C00DCQ38737416-754429FA-B555-4299-B7DA-816A51FC03BEQ38802154-61587913-7345-410A-9CF4-0B9C7EC32B87Q38826320-9732C9DD-006A-42F6-8C86-79634F76F91CQ42700762-97F8C467-0363-4404-BBB6-48BC87D01262Q49365756-DD62E5D3-9459-46E4-9CC5-2EE4A30DDE73Q58616102-0C327295-8234-464A-95EF-33CC413440DE
P2860
Evolution from WHO to EASL and mRECIST for hepatocellular carcinoma: considerations for tumor response assessment.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Evolution from WHO to EASL and ...... for tumor response assessment.
@en
type
label
Evolution from WHO to EASL and ...... for tumor response assessment.
@en
prefLabel
Evolution from WHO to EASL and ...... for tumor response assessment.
@en
P2093
P2860
P1476
Evolution from WHO to EASL and ...... for tumor response assessment
@en
P2093
Beom Kyung Kim
Seung Up Kim
P2860
P304
P356
10.1586/17474124.2015.959929
P577
2014-11-05T00:00:00Z